Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Victoza (liraglutide) and Wegovy (semaglutide) are both GLP-1 receptor agonists, and they share some similarities in their ability to lower the risk of heart-related problems in adults with heart disease. However, they have different primary uses and dosing schedules. Victoza is FDA-approved to treat Type 2 diabetes in people aged 10 and older and is injected once daily. It can also help with weight loss, but this is considered an off-label use and is a side effect of th medication. On the other hand, Wegovy is FDA-approved for long-term weight management in adults and children aged 12 and older with certain BMI criteria and is injected once a week. While both medications can cause side effects like nausea and diarrhea, Wegovy tends to cause these side effects more often. Additionally, both medications carry a risk of thyroid cancer and pancreatitis, but Wegovy also has warnings about potential eye problems and faster heart rates. Victoza is available as a lower-cost generic, while Wegovy is only available as a branded medication.
Victoza (liraglutide)
Wegovy (semaglutide)
Victoza (liraglutide)
Wegovy (semaglutide)
Summary of Victoza vs. Wegovy
Summary for GLP-1 agonist
Prescription only
Victoza (liraglutide) is a medication that's injected once a day. It helps lower blood sugar levels in people 10 years and older with Type 2 diabetes when used with a nutritious diet and regular exercise. It can also help lower the risk of heart-related problems in adults with Type 2 diabetes and heart disease. Victoza (liraglutide) belongs to the drug class called GLP-1 agonists. The medication comes as single-dose prefilled pens and is injected under the skin. It can cause side effects like nausea, vomiting, diarrhea, and constipation. Victoza (liraglutide) is available as both a brand-name and generic medication.
Summary for GLP-1 agonist
Prescription only
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. It comes in prefilled pens you use to inject the medication under the skin once a week. Wegovy (semaglutide) also comes as tablets that are swallowed once a day. This medication is approved for weight loss in some people. It can help lower the risk of heart attack, stroke, and death due to heart problems in adults with a larger body size and heart disease. The pens are also approved for certain adults with a liver problem called metabolic dysfunction-associated steatohepatitis (MASH). The medication works best when taken with a lower-calorie diet and regular exercise. Side effects include nausea, diarrhea, and stomach pain.
Indications of Victoza vs. Wegovy
Indications for
•Type 2 diabetes in people age 10 and older, together with a balanced diet and exercise
•Lowering the risk of serious heart-related problems in adults with Type 2 diabetes and heart disease